BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20032396)

  • 1. Development and characterization of HAT-sensitive Ewing tumour cells for immunotherapy.
    Pfeifle C; Reinhardt K; Heins S; Burdach S; Staege MS
    Anticancer Res; 2009 Nov; 29(11):4489-96. PubMed ID: 20032396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of the Ewing tumour-specific EWSR1-FLI1 mRNA by hammerhead ribozymes.
    Hühn R; Staege MS; Hesse M; Liebig B; Burdach SE
    Anticancer Res; 2009 Jun; 29(6):1901-8. PubMed ID: 19528446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets.
    Staege MS; Hutter C; Neumann I; Foja S; Hattenhorst UE; Hansen G; Afar D; Burdach SE
    Cancer Res; 2004 Nov; 64(22):8213-21. PubMed ID: 15548687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
    Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
    Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy.
    Staege MS; Hansen G; Baersch G; Burdach S
    Pediatr Blood Cancer; 2004 Jul; 43(1):23-34. PubMed ID: 15170886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel markers of subclinical disease for Ewing family tumors from gene expression profiling.
    Cheung IY; Feng Y; Danis K; Shukla N; Meyers P; Ladanyi M; Cheung NK
    Clin Cancer Res; 2007 Dec; 13(23):6978-83. PubMed ID: 18056173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
    J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ewing Sarcoma tumor cells express CD34: implications for autologous stem cell transplantation.
    Yaniv I; Stein J; Luria D; Cohen IJ; Liberzon E; Manor S; Grunshpan A; Sverdlov Y; Kodman Y; Issakov J; Feinmesser M; Zaizov R; Avigad S
    Bone Marrow Transplant; 2007 May; 39(10):589-94. PubMed ID: 17369866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
    Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
    Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of EWS-/FLI-1 gene fusion transcripts by RT-PCR as a tool in the diagnosis of tumors of the Ewing sarcoma group].
    Dockhorn-Dworniczak B; Schäfer KL; Dantcheva R; Blasius S; van Valen F; Burdach S; Winkelmann W; Jürgens J; Böcker W
    Verh Dtsch Ges Pathol; 1994; 78():214-9. PubMed ID: 7533989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications.
    Navarro S; Giraudo P; Karseladze AI; Smirnov A; Petrovichev N; Savelov N; Alvarado-Cabrero I; Llombart-Bosch A
    Anticancer Res; 2007; 27(4B):2457-63. PubMed ID: 17695539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors.
    Max D; Hesse M; Volkmer I; Staege MS
    Cancer Sci; 2009 Dec; 100(12):2383-9. PubMed ID: 19793082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
    García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
    Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
    Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cells are present in stem cell harvests of Ewings sarcoma patients and their persistence following transplantation is associated with relapse.
    Yaniv I; Cohen IJ; Stein J; Zilberstein J; Liberzon E; Atlas O; Grunshpan A; Sverdlov Y; Ash S; Zaizov R; Avigad S
    Pediatr Blood Cancer; 2004 May; 42(5):404-9. PubMed ID: 15049010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of genetic elements of intact and derivative chromosome 11 and 22 territories in nuclei of Ewing sarcoma cells.
    Taslerová R; Kozubek S; Bártová E; Gajdusková P; Kodet R; Kozubek M
    J Struct Biol; 2006 Sep; 155(3):493-504. PubMed ID: 16837212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of Ewing tumor cells to forced and activated p53 expression.
    Kovar H; Pospisilova S; Jug G; Printz D; Gadner H
    Oncogene; 2003 May; 22(21):3193-204. PubMed ID: 12761489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
    Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
    Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.
    Nishimori H; Sasaki Y; Yoshida K; Irifune H; Zembutsu H; Tanaka T; Aoyama T; Hosaka T; Kawaguchi S; Wada T; Hata J; Toguchida J; Nakamura Y; Tokino T
    Oncogene; 2002 Nov; 21(54):8302-9. PubMed ID: 12447693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antitumor immune response induced by fusion of dendritic cells and Ewing's sarcoma cells].
    Tang S; Guo W; Guo Y; Qu HY; Li DS
    Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(12):803-6. PubMed ID: 16083585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.